Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidized and oxidizable lipids are a broad class of molecules central to oxidative stress and regulated cell death pathways, particularly ferroptosis (Yin et al., 2011, Chem Rev; Stockwell et al., 2017, Cell). Oxidizable lipids, primarily polyunsaturated fatty acids (PUFAs), contain bis-allylic hydrogens that are highly susceptible to abstraction by reactive oxygen species, initiating a self-propagating chain reaction known as lipid peroxidation (Yin et al., 2011, Chem Rev). This process generates reactive lipid hydroperoxides and electrophilic aldehydes, such as 4-hydroxynonenal (4-HNE), which can damage cellular membranes and modify proteins (Yin et al., 2011, Chem Rev; Bochkov et al., 2010, Nat Rev Drug Discov). Oxidized phospholipids (OxPL) and oxidized low-density lipoprotein (OxLDL) act as damage-associated molecular patterns (DAMPs), promoting inflammation in diseases like atherosclerosis and non-alcoholic steatohepatitis (NASH) (Bochkov et al., 2010, Nat Rev Drug Discov; Witztum & Lichtman, 2003, Nature). Therapeutic strategies include the use of radical-trapping antioxidants (RTAs) like ferrostatin-1 to terminate peroxidation chains and the administration of deuterated PUFAs (e.g., RT001) that are chemically reinforced to resist oxidative attack (Stockwell et al., 2017, Cell; Shchepinov, 2007, BioEssays). Neutralizing these species or preventing their formation is a major focus for treating neurodegenerative diseases and ischemia-reperfusion injury (Stockwell et al., 2017, Cell; Bochkov et al., 2010, Nat Rev Drug Discov).
Inhibition of lipid peroxidation through radical trapping, enzymatic neutralization, or structural modification of lipid substrates (e.g., deuteration) to increase oxidative resistance.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidized and oxidizable lipids.